Table of Content

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Viral Vector Development Service Market Status and Forecast (2016-2027)
1.3.2 Global Viral Vector Development Service Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Viral Vector Development Service Supply by Company
2.1 Global Viral Vector Development Service Sales Value by Company
2.2 Viral Vector Development Service Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Viral Vector Development Service Market Status by Type
3.1 Viral Vector Development Service Type Introduction
3.1.1 Retroviral Vectors
3.1.2 Lentiviral Vectors
3.1.3 Adenoviral Vectors
3.1.4 Adeno-associated Viral Vectors
3.1.5 Others Viral Vectors
3.2 Global Viral Vector Development Service Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Viral Vector Development Service Market Status by Application
4.1 Viral Vector Development Service Segment by Application
4.1.1 Pharmaceutical Manufacturers
4.1.2 Biotechnology Companies
4.1.3 Research Institutes
4.2 Global Viral Vector Development Service Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Viral Vector Development Service Market Status by Region
5.1 Global Viral Vector Development Service Market by Region
5.2 North America Viral Vector Development Service Market Status
5.3 Europe Viral Vector Development Service Market Status
5.4 Asia Pacific Viral Vector Development Service Market Status
5.5 Central & South America Viral Vector Development Service Market Status
5.6 Middle East & Africa Viral Vector Development Service Market Status
6 North America Viral Vector Development Service Market Status
6.1 North America Viral Vector Development Service Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Viral Vector Development Service Market Status
7.1 Europe Viral Vector Development Service Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Viral Vector Development Service Market Status
8.1 Asia Pacific Viral Vector Development Service Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Viral Vector Development Service Market Status
9.1 Central & South America Viral Vector Development Service Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Viral Vector Development Service Market Status
10.1 Middle East & Africa Viral Vector Development Service Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Viral Vector Development Service Market Forecast by Type and by Application
12.1 Global Viral Vector Development Service Sales Value Forecast (2022-2027)
12.2 Global Viral Vector Development Service Forecast by Type
12.3 Global Viral Vector Development Service Forecast by Application
13 Global Viral Vector Development Service Market Forecast by Region/Country
13.1 Global Viral Vector Development Service Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 UniQure
14.1.1 Company Information
14.1.2 Viral Vector Development Service Product Introduction
14.1.3 UniQure Viral Vector Development Service Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 UJIFILM Diosynth Biotechnologies
14.2.1 Company Information
14.2.2 Viral Vector Development Service Product Introduction
14.2.3 UJIFILM Diosynth Biotechnologies Viral Vector Development Service Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Thermo Fisher Scientific (Brammer Bio)
14.3.1 Company Information
14.3.2 Viral Vector Development Service Product Introduction
14.3.3 Thermo Fisher Scientific (Brammer Bio) Viral Vector Development Service Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Spark Therapeutics
14.4.1 Company Information
14.4.2 Viral Vector Development Service Product Introduction
14.4.3 Spark Therapeutics Viral Vector Development Service Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 Sanofi
14.5.1 Company Information
14.5.2 Viral Vector Development Service Product Introduction
14.5.3 Sanofi Viral Vector Development Service Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 MassBiologics
14.6.1 Company Information
14.6.2 Viral Vector Development Service Product Introduction
14.6.3 MassBiologics Viral Vector Development Service Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 FinVector
14.7.1 Company Information
14.7.2 Viral Vector Development Service Product Introduction
14.7.3 FinVector Viral Vector Development Service Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 Cobra Biologics
14.8.1 Company Information
14.8.2 Viral Vector Development Service Product Introduction
14.8.3 Cobra Biologics Viral Vector Development Service Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
14.9 Cell and Gene Therapy Catapult
14.9.1 Company Information
14.9.2 Viral Vector Development Service Product Introduction
14.9.3 Cell and Gene Therapy Catapult Viral Vector Development Service Sales Value, Gross Margin and Global Share (2019-2021)
14.9.4 SWOT Analysis
15 Conclusion
16 Methodology

List of Figure

List of Tables

Table Global Viral Vector Development Service Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Viral Vector Development Service Sales Value (Million USD) by Company (2019-2021)
Table Global Viral Vector Development Service Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Viral Vector Development Service Sales Area
Table Viral Vector Development Service Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Viral Vector Development Service Sales Value (Million USD) by Type (2016-2021)
Table Global Viral Vector Development Service Sals Value Market Share by Type (2016-2021)
Table North America Viral Vector Development Service Sales Value (Million USD) by Type (2016-2021)
Table North America Viral Vector Development Service Sales Value Market Share by Type (2016-2021)
Table Europe Viral Vector Development Service Sales Value (Million USD) by Type (2016-2021)
Table Europe Viral Vector Development Service Sales Value Market Share by Type (2016-2021)
Table Asia Pacific Viral Vector Development Service Sales Value (Million USD) by Type (2016-2021)
Table Asia Pacific Viral Vector Development Service Sales Value Market Share by Type (2016-2021)
Table Central & South America Viral Vector Development Service Sales Value (Million USD) by Type (2016-2021)
Table Central & South America Pacific Viral Vector Development Service Sales Value Market Share by Type (2016-2021)
Table Middle East & Africa Viral Vector Development Service Sales Value (Million USD) by Type (2016-2021)
Table Middle East & Africa Viral Vector Development Service Sales Value Market Share by Type (2016-2021)
Table Global Viral Vector Development Service Sales Value (Million USD) by Application (2016-2021)
Table Global Viral Vector Development Service Value Market Share by Application (2016-2021)
Table North America Viral Vector Development Service Sales Value (Million USD) by Application (2016-2021)
Table North America Viral Vector Development Service Sales Value Market Share by Application (2016-2021)
Table Europe Viral Vector Development Service Sales Value (Million USD) by Application (2016-2021)
Table Europe Viral Vector Development Service Sales Value Market Share by Application (2016-2021)
Table Asia Pacific Viral Vector Development Service Sales Value (Million USD) by Application (2016-2021)
Table Asia Pacific Viral Vector Development Service Sales Value Market Share by Application (2016-2021)
Table Central & South America Viral Vector Development Service Sales Value (Million USD) by Application (2016-2021)
Table Central & South America Pacific Viral Vector Development Service Sales Value Market Share by Application (2016-2021)
Table Middle East & Africa Viral Vector Development Service Sales Value (Million USD) by Application (2016-2021)
Table Middle East & Africa Viral Vector Development Service Sales Value Market Share by Application (2016-2021)
Table Global Viral Vector Development Service Sales Value (Million USD) by Region (2016-2021)
Table Global Viral Vector Development Service Value Market Share by Region (2016-2021)
Table North America Viral Vector Development Service Sales Value (Million USD) by Country (2016-2021)
Table North America Viral Vector Development Service Value Market Share by Country (2016-2021)
Table Europe Viral Vector Development Service Sales Value (Million USD) by Country (2016-2021)
Table Europe Viral Vector Development Service Value Market Share by Country (2016-2021)
Table Asia Pacific Viral Vector Development Service Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Viral Vector Development Service Value Market Share by Country (2016-2021)
Table Central & South America Viral Vector Development Service Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Viral Vector Development Service Value Market Share by Country (2016-2021)
Table Middle East & Africa Viral Vector Development Service Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Viral Vector Development Service Value Market Share by Country (2016-2021)
Table Global Viral Vector Development Service Value (Million USD) Forecast by Type (2022-2027)
Table Global Viral Vector Development Service Value Market Share Forecast by Type (2022-2027)
Table Global Viral Vector Development Service Value (Million USD) Forecast by Application (2022-2027)
Table Global Viral Vector Development Service Value Market Share Forecast by Application (2022-2027)
Table Global Viral Vector Development Service Value (Million USD) Forecast by Region (2022-2027)
Table Global Viral Vector Development Service Value Market Share Forecast by Region (2022-2027)
Table UniQure Company Information
Table UniQure Product Introduction
Table UniQure Viral Vector Development Service Sales Value, Gross Margin and Global Share (2019-2021)
Table UJIFILM Diosynth Biotechnologies Company Information
Table UJIFILM Diosynth Biotechnologies Product Introduction
Table UJIFILM Diosynth Biotechnologies Viral Vector Development Service Sales Value, Gross Margin and Global Share (2019-2021)
Table Thermo Fisher Scientific (Brammer Bio) Company Information
Table Thermo Fisher Scientific (Brammer Bio) Product Introduction
Table Thermo Fisher Scientific (Brammer Bio) Viral Vector Development Service Sales Value, Gross Margin and Global Share (2019-2021)
Table Spark Therapeutics Company Information
Table Spark Therapeutics Product Introduction
Table Spark Therapeutics Viral Vector Development Service Sales Value, Gross Margin and Global Share (2019-2021)
Table Sanofi Company Information
Table Sanofi Product Introduction
Table Sanofi Viral Vector Development Service Sales Value, Gross Margin and Global Share (2019-2021)
Table MassBiologics Company Information
Table MassBiologics Product Introduction
Table MassBiologics Viral Vector Development Service Sales Value, Gross Margin and Global Share (2019-2021)
Table FinVector Company Information
Table FinVector Product Introduction
Table FinVector Viral Vector Development Service Sales Value, Gross Margin and Global Share (2019-2021)
Table Cobra Biologics Company Information
Table Cobra Biologics Product Introduction
Table Cobra Biologics Viral Vector Development Service Sales Value, Gross Margin and Global Share (2019-2021)
Table Cell and Gene Therapy Catapult Company Information
Table Cell and Gene Therapy Catapult Product Introduction
Table Cell and Gene Therapy Catapult Viral Vector Development Service Sales Value, Gross Margin and Global Share (2019-2021)